Evidence map›Paper›PMID 40236372›Full record

ArticleCureus2025

Acute Duodenal Ulcer Perforation Following Tirzepatide Treatment: A Case Report.

Maho Hayashi, Koji Hayashi, Yusuke Tsujigiwa, Seiko Uwafuji, Mamiko Sato, Yasutaka Kobayashi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maho HayashiDepartment of Internal Medicine, Fukui General Hospital, Fukui, JPN.
Koji HayashiDepartment of Rehabilitation Medicine, Fukui General Hospital, Fukui, JPN.
Yusuke TsujigiwaDepartment of Gastroenterology, Fukui General Hospital, Fukui, JPN.
Seiko UwafujiDepartment of Gastroenterology, Fukui General Hospital, Fukui, JPN.
Mamiko SatoDepartment of Rehabilitation Medicine, Fukui General Hospital, Fukui, JPN.
Yasutaka KobayashiGraduate School of Health Science, Fukui Health Science University, Fukui, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the case of a 36-year-old man with a history of type 2 diabetes mellitus (T2DM) and prior plantar necrotizing fasciitis, who initially improved on semaglutide but later experienced weight gain and elevated hemoglobin A1C (HbA1c) levels. After switching to tirzepatide, he developed nausea, epigastric pain, and vomiting. Shortly after increasing the tirzepatide dosage, he presented to the emergency room with severe abdominal pain. Diagnostic imaging revealed an ulcer in the duodenal bulb with free air, indicating acute duodenal ulcer perforation. The patient underwent emergency surgery, and postoperative tests confirmed a

Indexed as

drug-induced side effectsduodenal perforationduodenal ulcersgastroduodenal ulcerhelicobacter pyloriside-effects“tirzepatide”

Identifiers

PMID40236372
PMCPMC11999657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.